Functional Neuromodulation logo — Functional Neuromodulation is advancing deep brain stimulati...

Functional Neuromodulation

Functional Neuromodulation is advancing deep brain stimulation to treat mild Alzheimer's disease.

Founded 2011 United States Minneapolis, United States 5 employees Series A Total: $10.40M Health Care, Platforms

General Information

Company Name Functional Neuromodulation
Founded Year 2011
Location United States Minneapolis, United States
Employees 5
Industries Health Care, Platforms
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Functional Neuromodulation. To contact Functional Neuromodulation, visit fxneuromod.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Functional Neuromodulation compare?

A PDF of Functional Neuromodulation and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Functional Neuromodulation soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Functional Neuromodulation

Functional Neuromodulation is a health care startup founded in 2010 in the United States. The company's slogan, "Functional Neuromodulation is advancing deep brain stimulation to treat mild Alzheimer's disease," reflects its dedication to exploring innovative treatments for Alzheimer's. The startup is investigating the use of deep brain stimulation of the fornix (DBS-f) to drive neural activity and modulate the brain’s memory circuit. It completed a Phase II multi-center clinical trial of DBS-f in 42 patients with mild probable Alzheimer’s. The recent Series A investment of $10.40M on 17 October 2011 was led by Genesys Capital Management Inc and Medtronic. It's important to note that Functional Neuromodulation's work is still in the investigational stage and limited by Federal law to investigational use. The company is dedicated to advancing the application of DBS therapies to improve the lives of people with mild Alzheimer’s disease.

Business keywords: neuromodulation, deep brain stimulation, Alzheimer's disease, cognitive disorders, memory disorders, clinical studies, clinical trials, clinical research, dementia, neurology, neurosurgery, Mild Alzheimer's Disease, Alzheimer's Research, medical technology company, Toronto, Canada

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $10.40M 2
Genesys Capital Management Inc, Medtronic
17 Oct 2011

Functional Neuromodulation Alternatives & Competitors

View All Alternatives
Functional Neuromodulation vs
Oncoshot
Oncoshot Singapore

Made to connect cancer patients, hospitals, and industry with real-time insights.

Seed
20 employees
Digital Health, Health Care
Functional Neuromodulation vs

We bring biomarkers to the bedside...

Series D
10 employees
Biotechnology, Health Care
Functional Neuromodulation vs

A clinical-stage medical-device company innovating non-surgical, non-pharmacologic solutions for wei...

Debt Financing
4 employees
Biotechnology, Health Care

FAQ About Functional Neuromodulation

Functional Neuromodulation is advancing deep brain stimulation to treat mild Alzheimer's disease.
Functional Neuromodulation was founded in 2011.
Functional Neuromodulation is headquartered in Minneapolis, United States.
Functional Neuromodulation operates in Health Care and Platforms. Its work centres on neuromodulation, deep brain stimulation, Alzheimer's disease and cognitive disorders.
Functional Neuromodulation has approximately 5 employees.
Functional Neuromodulation has completed 1 funding round, raising a total of $10.40M. The latest funding stage is Series A.
Top alternatives and competitors to Functional Neuromodulation include Oncoshot, Biosystems International SAS, BAROnova. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Functional Neuromodulation and Oncoshot are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Functional Neuromodulation, https://bouncewatch.com/company/functional-neuromodulation, updated 29 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes